Since the pioneering studies using fetal cell transplants in Parkinson's disease (PD), brain repair by cell replacement has remained a long-standing and realistic goal for the treatment of neurodegenerative disorders including PD. Authentic and functional midbrain dopamine (DA) neurons can now be generated from human pluripotent stem cells (hPSCs) via a floor plate intermediate 1,2 , and these cell preparations are both safe and functional when transplanted to animal models of PD 3 . However, although resulting grafts from fetal brain tissue and hPSCs contain large numbers of desired DA neurons, these therapeutic cells are a minor component of the grafts. Moreover, the cellular composition of the graft has remained difficult to assess due to limitations in histological methods that rely on pre-conceived notions concerning cell types. Here, we used single cell RNA sequencing (scRNA-seq) combined with comprehensive histological analyses to characterize intracerebral grafts from ventral midbrain (VM)-patterned human embryonic stem cells (hESCs) and VM fetal tissue after long-term survival and functional maturation in a pre-clinical rat model of PD. The analyses revealed that while both cell preparations gave rise to neurons and astrocytes, oligodendrocytes were only detected in grafts of fetal tissue. On the other hand, a cell type closely resembling a class of newly identified perivascular-like cells was identified as a unique component of hESCderived grafts. The presence of these cells was confirmed in transplants from three different hESC lines, as well as from iPSCs. Thus, these experiments have addressed one of the major outstanding questions in the field of cell replacement in neurological disease by revealing graft composition and differences between hESC-and fetal cell-derived grafts, which can have important implications for clinical trials.
To compare the developmental potential of hESC-derived VM progenitors with fetal VM cells after transplantation in a rat model of PD, hESCs were subjected to VM-patterning by a well-established protocol intended for generation of clinicalgrade cell preparations 4 and human fetal tissue was dissociated from the VM of a 7.5
week old human embryo by the same protocol used for the fetal cell clinical transplantation trial, TRANSEURO 5 . Both types of cells were transplanted into the striatum of adult rats that had been unilaterally lesioned with 6-hydroxydopamine (6-OHDA) ( Fig. 1a ). Both fetal and hESC-derived cell preparations gave rise to grafts rich in DA neurons expressing tyrosine hydroxylase (TH) at six months following transplantation ( Fig. 1b ). In addition, paw use and rotational asymmetry induced by 6-OHDA lesioning was corrected in animals transplanted with hESC-derived VM progenitors, confirming a successful patterning of the cells prior to grafting and functional maturation after transplantation ( Fig. 1c and d) .
Cells were sampled for scRNA-seq both before grafting and 6 months after transplantation as illustrated in Figure 1a . To separate intact cells from cell fragments and debris, fetal and hESC-derived progenitors were isolated by fluorescence activated cell sorting (FACS) based on cell size (forward and side scatter) before grafting (Extended Data Fig. 1a ). t-distributed neighbor embedding (t-SNE) and graph-based clustering of the scRNAseq data from fetal and hESC-derived cells before grafting resulted in four major clusters (green, blue, orange and yellow in Fig.   1e ). The two top clusters (green, blue) consisted almost exclusively of VM-patterned hESCs while the two bottom clusters (orange, yellow) consisted mostly of fetal cells ( Fig. 1f ), suggesting that while both fetal and hESC-derived cells generate DA neurons with similar subtype specificities and functional properties after grafting 6, 7 , the two different sources of cells were transcriptionally distinct at the time of transplantation. Samseq was used to identify genes enriched in each cluster (Extended Data Table 1 ; Extended Data Fig. 2a, b ). Neural progenitor/radial glial cell markers including NES, SOX2, SOX9 and RFX4 were prominently expressed in the yellow fetal cell-dominated cluster as well as in the blue and green hESC-dominated clusters consistent with the expression of these genes also under DA neurogenesis in mouse and human 8, 9 (Fig. 1g ; Extended Data Fig. 2c ). Regulators of neurogenesis (NEUROG2, ASCL1, HES1 and HES5) were prominently expressed in the yellow fetal cell-dominated cluster while the blue and green hESC-dominated clusters mainly expressed HES1 8, 9 (Fig. 1h ; Extended Data Fig. 2d ). Importantly, transcription factors such as LMX1A, FOXA2 and OTX2 that are critical in ventral midbrain development and DA neurogenesis, as well as genes that are predictive of successful graft outcome (EN1 and DLK1) 10, 11 , were expressed by both fetal and hESC-derived cells (Fig. 1k , Extended Data Fig. 2e ). Cells in the fetal cell-dominated orange cluster ( Fig. 1e) expressed genes that are normally active in early developing neurons including DCX, NCAM1, SYT1 and STMN2, as well as genes that are normally expressed in maturing DA neurons including NR4A2, TH, DDC, PITX3 and PBX1 (Fig. 1i , j, k; Extended Data Fig. 2e , f, g). Of note, cells expressing markers for more mature DA neurons could be distinguished in one part of the orange cluster, thus indicating neuronal diversity among more mature fetal cells (Extended Data Fig. 2g ).
Expression of cell cycle genes and scores that assigned cells to different cell cycle phases indicated the presence of cycling cells within the blue (hESCs) and yellow (fetal) clusters ( Fig. 1l; Extended Data Fig. 3a ). From the list of enriched genes it is evident that the difference between the green and blue clusters correspond to cell cycle genes being expressed only in the blue cluster (Extended Data Table 1 ).
Markers of pluripotency (POU5F1, NANOG), mesoderm (T) or endoderm (SOX17) development were not expressed in any of the cell clusters (Extended Data Fig. 2h , i).
Six months after transplantation, when grafts had reached functional maturity, the transplants were dissected from the striatum, dissociated into a single cell suspension and subjected to FACS (see Fig 1a, Extended Data Fig. 1b ). The transplanted hESCs contained a GFP-encoding transgene expressed in virtually all transplanted cells (Extended Data Fig. 1e , g). Fetal cells did not carry a GFP-encoding transgene and were therefore isolated by FACS based on cell size (forward and side scatter) to separate single cells from debris ( Fig. 1a , Extended Data Fig. 1a ). Notably, since fetal cells did not express GFP, the vast majority of single cells isolated from fetal grafts were contaminating rat cells and scRNA-seq data from fetal transplants was therefore limited to only 63 fetal cells. In contrast, several hundred cells in each condition could be analyzed from hESC-derived grafted cells as well as from both fetal-and hESC-derived cells before grafting (Extended Data Fig. 1d ).
Using graph-based clustering, fetal and hESC-derived cells sampled from rat striatum six months after grafting segregated into four main clusters ( Fig. 2a ). We used Samseq 12 for the identification of genes enriched in each cluster (see Methods;
Extended Data Table 2 ; Extended Data Fig. 4b ). From inspection of the most highly enriched genes in each cluster it was evident that three of the clusters contained cells expressing genes characteristic of astrocytes (AQP4 and GFAP), oligodendrocytes (OLIG1 and OLIG2) and neurons (GAP43 and RBFOX3), respectively ( Fig. 2b-d , Extended Data Fig. 4c-e ). Of note, PMP2, one of the most significantly enriched genes in the oligodendrocyte cluster is a marker for peripheral Schwann cells in mouse but was recently shown to be prominently expressed in human oligodendrocytes 13 . In addition, dopaminergic markers including TH, SLC18A2 and DDC were expressed in cells in the neuron cluster indicating, as expected, a high proportion of DA neurons ( Fig. 2e , Extended Data Fig. 4f ). Further analyses of publicly available data sets reporting both bulk and scRNA sequencing provided additional strong support for the assignment into astrocytes, oligodendrocytes and neurons [13] [14] [15] [16] (Extended Data Fig. 5a ). Of note, despite transplantation of the cells at a highly proliferative stage, only a very small number of cells (1.3%) showed cell cycle scores indicative of some cycling cells after six months in vivo, and these cells all belonged to the oligodendrocyte and astrocyte clusters (Extended Data Fig. 3b ).
It is notable that the overall proportion of neurons relative to other cell types was remarkably low (<10%) in the scRNA-seq analysis from both fetal-and hESCderived grafts ( Fig. 2a ). This finding significantly diverged from the high neuronal content observed in previous histological analyses of rats grafted with VM-patterned hESCs 2, 10, [17] [18] [19] . We therefore further investigated the neuronal content in brain sections of animals grafted at the same time with the same preparation of hESCs/fetal cells that were used for sequencing. In contrast to the scRNA-seq data, a high neuronal content and extensive innervation that matches previous results 2,7,10 was observed also in these grafts (Extended Data Fig. 5b and c). The neuronal content of the hESC-derived grafts was further confirmed by comparing the number of NEUN + cells from this experiment as well as a representative separate experiment where a different preparation of cells was transplanted in a separate grafting session but according to the same procedure (Extended Data Fig. 5d , e). The apparent underrepresentation of neurons among recovered cells in the scRNA-seq data was not surprising considering difficulties to achieve complete mechanical dissociation of brain tissue into single cell suspensions of mature neurons containing extensive projections 14, 20 . Our data therefore underscores the importance of validating both qualitative and quantitative results from scRNA-seq data sets by alternative methods.
The scRNA-seq data also identified a fourth cluster of cells which could not, based on the top enriched genes, be easily assigned to a known neural cell type (Extended Data Table 2 ; Extended Data Fig. 4b ). Gene enrichment analysis using the top distinguishing genes of this cluster identified highly significant biological functions associated with vasculature and connective tissue, including genes encoding collagens and other extracellular components ( Fig. 2f ; Extended Data Fig. 6a and Extended Data Table 3 ). We then probed a large scRNA-seq data set from the mouse brain interrogating more than 400,000 cells organized into 250 annotated clusters representing diverse cell types such as central and peripheral neurons, astrocytes, oligodendrocytes, Schwann cells, immune cells, and brain vascular cell types 14 (Mouse Brain Atlas, http://mousebrain.org/). Interestingly, when this data set was searched for cell types co-expressing enriched genes of the fourth cluster, "enteric glia" and "vascular leptomeningeal cells" (VLMCs) were identified as cell type categories with highly related gene expression profiles (Extended Data Fig. 6b , c).
Enteric mesothelial fibroblasts, the closest matching cell type among "enteric glia", and VLMCs belong to a family of highly related organ barrier-forming fibroblast populations 14 . Recent scRNA-seq analyses have identified related cells associated with the mouse brain vasculature 15, 21 , characterized by the co-expression of Pdgfra, Col1a1, Col1a2, Lum and Dcn 14, 15, 21 . Interestingly, the human homologues of these genes were all expressed in the unknown cluster ( Fig. 2f , Extended Data Fig. 4g ).
Therefore, we refer to these cells as VLMCs as this cluster consists of cells with striking transcriptional resemblance to previously described populations of barrierforming fibroblasts, including VLMCs of the mouse central nervous system 14, 15, 21 .
The analysis of graft composition uniquely allowed us to discern similarities and potential differences between the cellular composition of fetal and hESC-derived grafts after transplantation. Strikingly, tracing the origin of grafted cells visualized by t-SNE suggested prominent differences in generated cell types ( Fig. 2g ). Accordingly, two of the clusters (astrocyte and neuron clusters) contained cells both from grafted VM-patterned hESCs and from fetal cells. In contrast, the oligodendrocyte cluster contained only fetal-derived cells while the VLMC cluster contained only hESCderived cells (Fig. 2g ). The scRNA-seq analysis of cells after grafting thus suggested that VM-patterned hESCs and fetal VM cells have distinct developmental potential after grafting. Based on the unexpected identification of VLMCs in the hESC grafts, we examined highly expressed genes found in the VLMC cluster (COL3A1, FBLN1, S100A11 and IFITM2), and additional genes encoding components of the extracellular space (e.g. EMP2 and MMP2), also in the cells prior to grafting (Extended Data Fig.   6d ). We found that several of these VLMC-associated genes were expressed together with DA progenitor markers in the same hESC-derived cells suggesting that a common hESC-derived precursor has potential for generation of neurons, astrocytes and VLMCs.
To validate the key observations from the scRNA-seq analysis, and to investigate in more detail the properties of graft-derived VLMCs, we first confirmed the presence of VLMCs in brain sections of animals grafted in parallel with the same batches of cells that were used for scRNA-seq. Using antibodies recognizing both rodent and human COL1A1 (uniquely expressed in the VLMC cluster among the transplanted cells), and an antibody that is specific for the human protein (hCOL1A1)
we confirmed the presence of VLMCs in the hESC-derived grafts (Fig. 2h , i). These COL1A1 + cells in the hESC-derived grafts were commonly located in close association with blood vessels penetrating into grafts (arrows in Fig. 2h ), which is consistent with previous studies describing VLMCs associated with the brain vasculature 14, 15, 21 . The analysis indicated that the hESC-derived VLMCs were intermingled with rat cells of similar appearance and location within the transplants (Fig 2h, i ), suggesting that cells originating from both host and hESCs contributed to the graft vasculature as has been reported for rodent-to-rodent neural transplants 22, 23 .
Co-labeling of TH and hCOL1A1 in transplants from the same fetal cells grafted at the same time as the cells used for sequencing showed that very few if any hCOL1A1-expressing cells were present (Fig. 2j ), and co-labeling of hCOL1A1/COL1A showed that the cells associated with the vasculature in these grafts were exclusively host derived (Extended Data Figure 7a ). The lack of VLMCs in fetal VM grafts was confirmed in an additional transplant experiment using tissue from another 7.5 week old embryo ( To assess if the identification of VLMCs in the hESC-grafts apply also to other cell lines and differentiation protocols, we next assessed the presence of VLMCs in grafts from previous transplantation experiments using VM-patterned progenitors derived from three different hESC lines: RC17 (GMP protocol showing minimal variability 4 ), H9 (research grade protocol) and HS980 4,6,7,10 (GMP protocol) ( Fig. 3a-c) , and an iPSC line (GMP protocol) where the cells were sorted for DA progenitor marker prior to grafting ( Fig. 3d) 24 . Importantly, graft derived hCOL1A1 + cells were present in all analyzed VM-patterned hPSC-derived grafts independent of cell line or differentiation protocol ( Fig. 3a-d) . Clinical delivery will be of cells that have been cryopreserved prior to transplantation, and VLMCs were shown to be present to a similar extent in grafts from fresh and cryopreserved cells ( Fig. 3e , f).
To investigate if the derivation of VLMCs was a characteristic uniquely associated to the specific differentiation protocols used in this study, we assessed hESCs after terminal differentiation in vitro using two additional recently published protocols for generating VM progenitors from hPSCs 11,25 see also https://patents.justia.com/patent/20180094242) as well as in three-dimensional selforganized organoids. These protocols all gave rise to cultures that are rich in TH + neurons and also cells co-expressing VLMC markers COL1A1 ( The scRNA-seq analysis of grafted cells show that hESC-derived transplanted cells give rise to neurons, astrocytes and VLMCs, but not to oligodendrocytes. In these experiments detection of GFP (from the SYN-GFP transgene) was used to isolate grafted hESC-derived cells by FACS. To validate and extend the findings, hESCs patterned by the same protocol as initially used ( Fig. 1 and 2) were grafted to the midbrain of nude rats and analyzed by scRNA-seq after 9 months of in vivo maturation ( Fig. 4a-d) . Importantly, to ensure that the GFP reporter and method of cell isolation did not influence/bias the results, cells were in the new experiment sequenced either directly after dissociation or after FACS isolation (outlined in Fig. 4a ). In addition, the 10X Genomics Platform was used to allow for higher throughput. After QC and filtering to exclude rat cells (see Extended Data Fig.   8a -c), a total of 7875 cells were retained for analysis. The resulting UMAP embedding and graph-based clustering showed that, as with the hESC-derived cells grafted to the striatum (Fig. 2) , VM-patterned hESCs transplanted to the midbrain gave rise to three main clusters which, based on marker expression, were clearly classified as astrocytes, neurons and VLMCs ( Fig. 4e -i; Extended Data Table 4 ). A small number of cells expressing astrocyte markers expressed cycling genes and clustered separately ( Fig. 4e ). Similar results were derived regardless of whether cells had been isolated and sequenced directly or isolated by FACS before sequencing ( Fig.   4j ).
Next, data from all hESC-derived grafted cells (in total 8558 cells) was integrated (683 cells grafted to the striatum; Smartseq2 sequencing and 7875 cells grafted to the midbrain; 10X Genomics) by using the Seurat data integration strategy 26 . Cells grafted to the striatum (sorted and subjected to Smartseq2 sequencing) and to the midbrain (sorted and unsorted, subjected to 10X Genomics) were all distributed in the main clusters (Extended Data Figures 9 and 10; see also enriched markers in Extended Data Table 5 ). Thus, VM-patterned hESC-derived cells formed the three major cell types (astrocytes, neurons and VLMCs) regardless of how they were isolated (direct isolation or FACS) and independent of grafting site (striatum or midbrain). In addition, similar to when cells were grafted to the striatum, the midbrain grafts resulted in a low yield of recovered neurons, but in the integrated data set the total number of analyzed neurons was substantially increased (from 35 to presented here support the conclusion that these cells are safe to use in cell therapy.
Third, scRNA-seq of fetal and hESC-derived grafted cells demonstrated that oligodendrocytes are only generated from fetal cells. Although the number of sequenced fetal cells was low, this finding was firmly validated in comprehensive histological analyses of several fetal and hESC-derived grafts. Fourth, the transcriptional profiling also revealed that hESC-derived grafts contained a cell type, that was previously not known to be part of the graft. These cells resembled normal vascular fibroblasts/VLMCs that have recently been identified in the mouse brain using scRNA-seq 15, 21 . The graft-derived VLMCs were localized around blood vessels intermingled with endogenous vascular cells. The presence of graft-derived VLMCs could potentially be beneficial for graft survival, maturation and function by promoting a rapid vascularization and re-establishment of the blood brain barrier.
They might also affect the immunological profile of the graft, and thus the immune response of the host, which is an important aspect to consider when designing and interpreting the first clinical trials using hESC-derived cells.
Methods

Animals
Athymic nude female rats (180g) were purchased from Harlan laboratories (Hsd:RH- For intranigral grafts of hESC-derived VM progenitors, we injected a total of 150 000 cells over 2 deposits (75.000 cells per deposit) to the midbrain at the following coordinates AP:-5.2; ML-2.3; DV-6.0/-6.5; TB flat head. At each deposit the injection-cannula was left in place for an additional 2 minutes before careful retraction to allow for settling of the tissue. The maturation of the graft was monitored using d-amphetamine induced rotations as described above. On the day before perfusion a second cylinder test was performed. After behavioral data had been collated, the rats were transcardially perfused using 50 ml physiological saline solution (8.9% Saline) over 1 minute followed by 250ml 4% PFA (pH7.4) solution over 5 minutes. For hESC-derived DA progenitors eight animals were transplanted in the intrastriatal grafting experiments. One rat had no graft and the remaining seven were used for analysis (two for sequencing and five for histology). For the intranigral transplants, nine rats were transplanted: one died after surgery, two were used to ensure good graft survival and maturation after six months and the remaining six were kept until the nine month endpoint. At this time three were used for sequencing and three for histology.
Human Fetal Tissue preparation
Human fetal tissue from a legally terminated embryo was collected in accordance with existing guidelines with approval of the Swedish National Board of Health and Welfare and informed consent from women seeking elective abortions. To determine the gestational age of the embryo, the crown-to-rump length was measured and the embryo were staged according to week post-conception. To further assess the presence of VLMCs after in vitro differentiation we adopted two additional recently published/patented protocols that are intended for clinical use 11, 25 (see also https://patents.justia.com/patent/20180094242). For VMpatterned organoid differentiation RC17 hESCs were differentiated into selforganized organoids as described 28 , in presence of CHIR (CHIR99021) and SHH (SHH-C24II) for midbrain patterning 7 .
Tissue dissociation and FACS sorting
Grafted human fetal ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum (n=2 for fetal VM intrastriatal grafts, n=2 for hESC intrastriatal grafts and 3 for intranigral grafts) and dissociated into a single cell suspension using the papain kit (Worthington) as previously described 29 . After dissociation, the cells were FACS sorted based on size (fetal tissue) or GFP expression (VM-patterned hESCs) using BD FACSAria III Cell Sorter (Extended Data Fig. 1a and b ). The single cell suspension of human fetal ventral midbrain and VM-patterned hESCs before grafting were FACS sorted based on size. Tissue from individual animals were processed and sequenced separately.
Library Preparation and Sequencing
The cDNA libraries from the sorted cells were generated using the Smartseq2 protocol 30 . cDNA libraries were tagmented as previously described, using a homemade Tn5 enzyme 31 
Read alignment and quality control
Reads for Smartseq2 data were aligned to the human genome (hg19) merged with GFP and TVA sequences using STAR v2.3.0 32 and filtered for uniquely mapping reads. Gene expression was calculated as reads per kilobase gene model and million mappable reads (RPKMs) for each transcript in Ensembl release 69 using rpkmforgenes 33 . To exclude the contaminated rat cells, kallisto software was used for mapping of reads to the rat genome. The low-quality libraries were filtered out based on following parameters: < 5% uniquely mapping reads, > 25% fraction mismatches, < 10% exon mapping reads, >20% 3'mapping, < 3% or > 30% of all genes detected, < 10000 normalization reads, > 10% reads mapped to rat genome (Extended Data Fig.   1c ). From 2206 sequenced cells 1406 passed the quality control.
For 10X Genomics samples, raw base calls were demultiplexed and converted to sample specific fastq files using cellranger mkfastq program. Raw reads were processed using cellranger count version 3 pipeline using default parameters.
Precisely, this pipeline uses STAR to map cDNA reads to the transcriptome (GRCh38). Only exonic reads that uniquely mapped to transcriptome were used for the downstream analysis. Aligned reads were filtered for valid barcodes and UMI and observed cell barcodes were retained if they were 1-Hamming-distance away from entering into the whitelist of barcodes. Non-homopolymer UMIs with quality score greater than 10 were retained. Distribution of UMIs in each unique cell barcodes was examined and cell barcodes with UMI counts that fell within the 99 th percentile of the defined range of estimated cell count were selected. Cells were excluded if more than 10% reads aligned to Rat genome (Rnor6) (Extended Data Fig 8c) . Low quality cells were filtered out based on: a) fraction of UMIs mapping to mitochondria larger than 0.15 and b) log10 detected genes per cell (nGene) below mean minus two standard deviations for each sample separately (Extended Data Fig 8b) . A total of 7875 cells were used for downstream analysis.
Smartseq2 cell population definition
Seurat package 34 version 2.2.0 was used to normalize the data by gene detection and to extract the variable genes which were used for downstream analysis (x.low.cutoff = 1, x.high.cutoff = 10, y.cutoff =1). Only statistically significant principal components were included (Cells after grafting -PC: 1-12, Cells before grafting-PC:1:6, 8, 10:12). Clusters have been defined with Seurat function FindClusters using resolution 0.6. This gave five clusters for the cells before grafting (Extended Data Fig. 2a ) and seven clusters for the cells after grafting (Extended Data Fig. 4a ). After analysis of differentially expressed genes between the clusters, clusters with few differentially expressed genes between them and close proximity on the tSNE were manually defined as a single cluster, which gave 4 clusters for cells before grafting and 4 clusters for cells after grafting ( Fig. 1e and 2a ). The clustering results were visualized with the t-SNE plot (Rtsne: T-Distributed Stochastic Neighbor Embedding using a Barnes-Hut implementation, https://github.com/jkrijthe/Rtsne). To extract the clusterspecific genes we used the Samseq software package 12 . Differentially expressed genes for each cluster are in Extended Data table 1 and 2. Genes were considered significantly differentially expressed if q-value < 0.01.
Integrated analysis
All clustering and analysis was performed with Seurat v3.0.0 26 . Cells from each rat graft was merged into individual datasets as well as grafted cells originating from hESCs in the SmartSeq2 dataset. Each dataset was log normalized and scaled with regression of number of features. The four datasets were integrated using the strategy Table 4 and 5). Genes were considered significantly differentially expressed if padj-value < 0.05.
Pathway Analysis
The gene clusters after transplantation (genes from Extended Data table 2) were analyzed for biological functions using the Ingenuity Pathway Analysis program (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathwayanalysis). Only functional categories related to System Development functions were selected (Extended Data table 3) and ten most significant System Development functions of each cluster were plotted in Extended Data Fig. 6a .
Comparison with other data sets
Gene expression profiles per cluster from the Mouse brain atlas 14 was downloaded from their website (http://mousebrain.org). A marker gene set consisting of top 100 up-regulated gene per cluster among the cells after grafting (for either Smartseq2 data alone or integrated with 10x data), combined with marker genes for all the 256 cell types in the atlas was used in the comparison (Extended Data Fig. 6b, 6c, 11) . The 256 atlas cell types were grouped into main clusters at Taxonomy rank 4 (39 groups) and mean expression per group was calculated using the marker gene set. These were compared to the mean expression in our clusters using spearman correlation.
Cell Cycle Scores
G2M and S phase scores were calculated using the function CellCycleScoring in the Seurat package. As described 35 the cells were classified as cycling if either of the scores were larger than 1. If scores were less than 1 they were defined as non-cycling.
Immunohistochemistry
After perfusion, brains were post-fixed for 24 hours in 4% PFA and then cryopreserved in a 30% sucrose solution before being sectioned coronally on a freezing sledge microtome at a thickness 35µm in series of 1:8 or 1:12. The hESC graft in Fig. 1b , 3b-f and Extended Fig. 1d -f has previously been analyzed for a different purpose and published 10, 4, 24 . The micrographs presented here are derived uniquely for this study.
Immunocytochemistry
Terminally differentiated cell cultures (day 42-52) were fixed in 4% PFA for 15 min and then washed three times with PBS. For immunocytochemistry, the cells were After incubation with primary antibodies over night at 4°C, the cells were washed three times before adding fluorophore-conjugated secondary antibodies (1:200, Jackson ImmunoResearch Laboratories) and DAPI (1:500). The cultures were incubated with secondary antibodies for 2 hours and finally washed three times.
Microscopy
Images were captured using either a flatbed scanner Epson Perfection V850 PRO, a Leica DMI6000B widefield microscope or a Leica TCS SP8 laser scanning confocal microscope. The image acquisition software was Leica LAS X and images were processed using Volocity 6.5.1 (Quorum Technologies) and Adobe Photoshop . Any adjustments were applied equally across the entire image, and without the loss of any information. The following images were digitally stitched from multiple images: Fig.   1a -b, Fig. 2h, Fig. 3a-f, Fig. 4 , Extended Data Fig. 1d, Extended Data Fig, 5d , Extended Data Fig. 7a , c, m. Indicated genes are established markers for astrocytes, VLMCs, neurons and DA neurons, respectively. All indicated markers were significantly enriched in clusters marked as "Astrocyte", "VLMC" and "Neuron", respectively. j, t-SNE of grafted cells as shown in Fig. 4e . Cells isolated by FACS (blue) or not by FACS (magenta) are indicated. 
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